Feasibility measures
ADVERSE EVENTS
Overall feasibility was calculated as a percentage of (1) treatment completion; (2) measurement fulfillment at T1, T2, and T3; (3) dropout rates between the NeuroACT group and the TAU group post randomization; (4) treatment credibility; and (5) any adverse events as reported in participants’ medical records, according to the CONSORT statement for randomized trials of nonpharmacological treatments (Treatment credibility was assessed using an ASD-adapted version of the Treatment Credibility Scale (TCS) (